series-c-plus
Stage
1
Investors
About
Virogin is a clinical-stage immuno-oncology company developing innovative oncolytic virotherapy and mRNA vaccine therapies for cancer treatment.
Explore Virogin's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.